The Handmaid's Tale is getting deeper into its sixth season, and Janine's arc is helping to make the show even better.

Gilead Sciences is just a few weeks away from an FDA decision on seladelpar for rare liver disease primary biliary cholangitis (PBC) and will be buoyed by new data pointing to its long-term ...